Categories Analysis, Technology
AAPL Stock: Despite sales slowdown, Apple remains a safe investment
iPhone sales recovered and grew 10% annually in the fourth quarter, but fell short of expectations
For Apple Inc. (NASDAQ: AAPL), 2022 has been a mixed year with the gadget giant experiencing a slowdown initially, followed by a rebound marked by strong sales in the latter part of the year. Though the general demand slump in the tech market and underwhelming response to the latest iPhone launch weighed on investor sentiment, Apple remains a good investment.
The Stock
After peaking in January this year, Apple’s stock experienced high fluctuation with a series of ups and downs. Of late, it has been maintaining a steady uptrend. The stock witnessed one of the biggest single-day gains last week after the company reported fourth-quarter results. Analysts are almost unanimous in their buy recommendation for AAPL, citing the bullish outlook that signals double-digit gains over the next twelve months.
When it comes to the product portfolio, all key Apple gadgets performed well in recent quarters except iPad which continues to experience weakness, especially after the messy launch of the new version recently. Meanwhile, the management’s recent warning of a sales slowdown in the holiday season came as a disappointment for the company’s stakeholders.
Apple inc. Q4 2022 Earnings Call Transcript
But the tech firm’s long-term prospects look intact, given the record sales across all geographical regions in the most recent quarter. Moreover, Apple’s products are performing exceptionally well in emerging markets, like Southeast Asia, Latin America, and India. As far as market expansion is concerned, recent improvements in the semiconductor supply chain bode well for the company.
Risks
That said, the unfavorable economic environment, marked by elevated inflation and geopolitical issues, would remain a dampener in the near future. Considering the impact of those headwinds, Apple executives have warned of a sales slowdown in the final months of the year, with Mac sales declining on an annual basis and services growth decelerating.
From Apple’s Q4 2022 earnings conference call:
“Overall, we believe total company year-over-year revenue performance will decelerate during the December quarter as compared to the September quarter for a number of reasons. First, we expect nearly 10 percentage points of negative year-over-year impact from foreign exchange. Second, on Mac, in addition to increasing FX headwinds, we have a very challenging comparison against last year which had the benefit of the launch and associated channel feel of our newly redesigned MacBook Pro with M1.”
Ends FY22 Well
Apple ended the fiscal year on a high note, reporting broad-based sales growth that drove fourth-quarter revenues to an all-time high of around $90 billion. With a 10% annual growth, iPhone sales rebounded from the slump that began at the beginning of the year, but the latest number fell short of expectations. Reflecting the strong top-line performance, September quarter earnings rose 4% to $1.29 per share. Total revenues and earnings also topped Wall Street’s expectations, as they did in the trailing quarters. During the quarter, the active installed base of devices climbed to a new all-time high.
Earnings Infographic: Microsoft Q1 revenue up 11%; earnings beat
Extending the post-earnings rally, AAPL ended the last trading session sharply higher. Over the past 30 days, the shares have gained nearly 6%.
____________________________________________________________________________________________________________________
Related Posts:
Apple (AAPL) Q3 revenue rises 11% as iPhone sales rebound; results beat
Apple (AAPL) Q2 Earnings: Key highlights in four charts
Apple (AAPL) reports record-high Q1 revenue as iPhone sales rise 8%; stock gains
Understanding Apple (NASDAQ: AAPL) Q4 2019 earnings results through 4 charts
Related Tickers:
_____________________________________________________________________________________________________________________
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on